The elevated neurodegenerative markers (S100B, GFAP, and NSE) in both the prediabetes (PD) and T2D groups indicate ongoing neurovascular damage and an increased stroke risk that begins to emerge in the prediabetic stage and intensifies with progression to T2DM. This evidence concerns the gene ENO2 and stroke disorder.